Alex Therapeutics
PrivateLast Round
Series A
Mar 3, 2023
Total Funding Raised
$9.24M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Alex Therapeutics operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Series A round in March 2023.
Alex Therapeutics is a healthtech company that develops and licenses clinically validated digital therapeutics (DTx) and companion apps in partnership with pharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alex Therapeutics Comparables
Compare Alex Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dawn Health | 83% | |
| Amalgam Rx | 80% | |
| BrightInsight | 79% |
For institutional investors. Book with your work email.
Alex Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 3, 2023 | ||||
| Series A | Apr 6, 2022 | ||||
| Grant | Jun 4, 2021 | ||||
| Seed | Jul 23, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alex Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovestor | Series A |
| Vinnova | Grant |
| Bonit Capital | Series A |
| South Bay Ventures | Series A |
| Sweet Studio | Series A, Seed |
| Hadean Ventures | Series A |
| Scale Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 66% MoM.
- Jul 27, 2026
Monthly visitors grew 380% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
Alex Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alex Therapeutics's valuation, stock price, and market status.
Is Alex Therapeutics a public or private company?
Alex Therapeutics is a private company.
What is the current stock price of Alex Therapeutics?
Alex Therapeutics is a private company, so its shares have no public market price. Caplight tracks Alex Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alex Therapeutics worth (valuation)?
Valuation information for Alex Therapeutics is not publicly available.
Can I buy Alex Therapeutics stock?
Alex Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alex Therapeutics's last funding round?
Alex Therapeutics's most recent funding round was Series A on March 3, 2023.
Who are the main investors in Alex Therapeutics?
Key investors in Alex Therapeutics include Innovestor, Sweet Studio, Hadean Ventures.
Will Alex Therapeutics IPO soon?
No public IPO plans have been announced for Alex Therapeutics.
How can I track Alex Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Alex Therapeutics's shares on secondary markets.